Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6002)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 24, 2021 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Blomstrand H, Batra A, Cheung WY, Elander NO. Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer. World J Clin Oncol 2021; 12(9): 787-799 [PMID: 34631442 DOI: 10.5306/wjco.v12.i9.787] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i9/787.htm |
| Number | Citing Articles |
| 1 |
Yvonne L. Eaglehouse, Sarah Darmon, Amie B. Park, Craig D. Shriver, Kangmin Zhu. Treatment of pancreatic adenocarcinoma in relation to survival in the U.S. Military Health System. Cancer Epidemiology 2024; 88: 102520 doi: 10.1016/j.canep.2023.102520
|
| 2 |
Wolfgang P. Fendler, Kim M. Pabst, Lukas Kessler, Pedro Fragoso Costa, Justin Ferdinandus, Manuel Weber, Maria Lippert, Katharina Lueckerath, Lale Umutlu, Karina Kostbade, Ilektra A. Mavroeidi, Martin Schuler, Marit Ahrens, Christoph Rischpler, Sebastian Bauer, Ken Herrmann, Jens T. Siveke, Rainer Hamacher. Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities. Clinical Cancer Research 2022; 28(19): 4346 doi: 10.1158/1078-0432.CCR-22-1432
|
| 3 |
Jakub Liu, Magdalena Mroczek, Anna Mach, Maria Stępień, Angelika Aplas, Bartosz Pronobis-Szczylik, Szymon Bukowski, Magda Mielczarek, Ewelina Gajewska, Piotr Topolski, Zbigniew J. Król, Joanna Szyda, Paula Dobosz. Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer. Cancers 2023; 15(3): 779 doi: 10.3390/cancers15030779
|
| 4 |
Wenjie Lu, Lantian Wang, Xiawei Li, Kezhong Tang. Efficacy and safety of FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy: A systematic review and meta-analysis. Journal of International Medical Research 2022; 50(4) doi: 10.1177/03000605221093225
|
| 5 |
Chuan Qian, LiIi Wan, Yakun Wu. Analysis of the results of high-intensity focused ultrasound for patients with advanced pancreatic cancer. International Journal of Hyperthermia 2023; 40(1) doi: 10.1080/02656736.2023.2250586
|
| 6 |
Giulia Orsi, Alessandro Cavaliere, Giampaolo Tortora, Sara Lonardi, Marina Macchini, Mariacristina Di Marco, Guido Giordano, Enrico Vasile, Mario Scartozzi, Silvia Bozzarelli, Silvia Noventa, Maria Grazia Rodriquenz, Anna Maria Militello, Ilario Giovanni Rapposelli, Ingrid Garajova, Stefania De Lorenzo, Barbara Merelli, Alessandro Bittoni, Lisa Salvatore, Letizia Procaccio, Chiara Paratore, Andrea Spallanzani, Umberto Peretti, Monica Niger, Elisa Giommoni, Ilaria Bernardini, Emiliano Tamburini, Katia Bernardino, Laura Forti, Maria Maddalena Valente, Stefano Cascinu, Michele Milella, Michele Reni. Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv). British Journal of Cancer 2023; 128(5): 877 doi: 10.1038/s41416-022-02086-w
|
| 7 |
Luis Marti-Bonmati, Leonor Cerdá-Alberich, Alexandre Pérez-Girbés, Roberto Díaz Beveridge, Eva Montalvá Orón, Judith Pérez Rojas, Angel Alberich-Bayarri. Pancreatic cancer, radiomics and artificial intelligence. The British Journal of Radiology 2022; 95(1137) doi: 10.1259/bjr.20220072
|
| 8 |
Lei Deng, Ziyu Fan, Xiaojun Xiao, Hui Liu, Jiaxuan Zhang. Dual-Channel Heterogeneous Graph Neural Network for Predicting microRNA-Mediated Drug Sensitivity. Journal of Chemical Information and Modeling 2022; 62(23): 5929 doi: 10.1021/acs.jcim.2c01060
|
| 9 |
Heng‐Chung Kung, Jun Yu. Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study. MedComm 2023; 4(2) doi: 10.1002/mco2.216
|
| 10 |
Andrea Pretta, Dario Spanu, Stefano Mariani, Nicole Liscia, Pina Ziranu, Valeria Pusceddu, Marco Puzzoni, Elena Massa, Mario Scartozzi, Eleonora Lai. How to improve metastatic pancreatic ductal adenocarcinoma patients’ selection: Between clinical trials and the real-world. World Journal of Clinical Oncology 2022; 13(5): 417-422 doi: 10.5306/wjco.v13.i5.417
Abstract(666) |
Core Tip(532) |
Full Article(HTML)(1426)
|
Full Article (PDF)-895K(223)
|
Full Article (Word)-228K(95)
|
Audio-1486K(1)
|
Peer-Review Report-188K(83)
|
Answering Reviewers-85K(100)
|
Times Cited (0)
|
Total Visits (5232)
|
Open
|
| 11 |
Lifeng Ran, Wei Yang, Xing Chen, Jun Zhang, Kun Zhou, Hui Zhu, Chengbing Jin. High-Intensity Focused Ultrasound Ablation Combined With Pharmacogenomic-Guided Chemotherapy for Advanced Pancreatic Cancer: Initial Experience. Ultrasound in Medicine & Biology 2024; 50(10): 1566 doi: 10.1016/j.ultrasmedbio.2024.06.013
|
| 12 |
Sai Sandeep Annamaraju, Sai Charitha Mullaguri, Sharat Putta, Ravikanth Vishnubhotla, Rama Krishna Kancha. Biomedical Aspects of Solid Cancers. 2024; : 73 doi: 10.1007/978-981-97-1802-3_7
|
| 13 |
Yvonne L. Eaglehouse, Sarah Darmon, Michele M. Gage, Craig D. Shriver, Kangmin Zhu. Characteristics Associated With Survival in Surgically Nonresected Pancreatic Adenocarcinoma in the Military Health System. American Journal of Clinical Oncology 2024; 47(2): 64 doi: 10.1097/COC.0000000000001057
|
| 14 |
Cheng-Yu Tang, Shih-Hung Yang, Chung-Pin Li, Yung-Yeh Su, Sz-Chi Chiu, Li-Yuan Bai, Yan-Shen Shan, Li-Tzong Chen, Shih-Chang Chuang, De-Chuan Chan, Chia-Jui Yen, Cheng-Ming Peng, Tai-Jan Chiu, Yen-Yang Chen, Jen-Shi Chen, Nai-Jung Chiang, Wen-Chi Chou. Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer. Pancreatology 2024; doi: 10.1016/j.pan.2024.03.014
|